» Articles » PMID: 1733777

Shortened Cecropin A-melittin Hybrids. Significant Size Reduction Retains Potent Antibiotic Activity

Overview
Journal FEBS Lett
Specialty Biochemistry
Date 1992 Jan 20
PMID 1733777
Citations 80
Authors
Affiliations
Soon will be listed here.
Abstract

We have earlier reported two 26-residue antibacterial peptides made up from different segments of cecropin A (CA) and melittin (M). We now report a substantial reduction in size at the C-terminal section of the highly active hybrid CA(1-8)M(1-18), leading to a series of 20-, 18- and 15-residue analogs with antibiotic properties similar to the larger molecule. In particular, the 15-residue hybrids CA(1-7)M(2-9), CA(1-7)M(4-11) and CA(1-7)M(5-12) are the shortest cecropin-based peptide antibiotics described so far, with antibacterial activity and spectra similar or better than cecropin A and a 60% reduction in size. Their reduced size and highly alpha-helical structure require an alternative mechanism for their interaction with bacterial membranes.

Citing Articles

Optimizing lipopeptide bioactivity: The impact of non-ionic surfactant dressing.

Abraham A, Gyulai G, Mihaly J, Horvath A, Dobay O, Varga Z J Pharm Anal. 2025; 14(12):101020.

PMID: 39881961 PMC: 11774939. DOI: 10.1016/j.jpha.2024.101020.


Effect of Chirality and Amphiphilicity on the Antimicrobial Activity of Tripodal Lysine-Based Peptides.

Adak A, Castelletto V, de Mello L, Mendes B, Barrett G, Seitsonen J ACS Appl Bio Mater. 2025; 8(1):803-813.

PMID: 39792083 PMC: 11752523. DOI: 10.1021/acsabm.4c01635.


Segment-Based Peptide Design Reveals the Importance of N-Terminal High Cationicity for Antimicrobial Activity Against Gram-Negative Pathogens.

Mechesso A, Zhang W, Su Y, Xie J, Wang G Probiotics Antimicrob Proteins. 2024; 17(1):15-34.

PMID: 39377976 DOI: 10.1007/s12602-024-10376-3.


Dual Antimicrobial and Anticancer Activity of Membrane-Active Peptide BP52.

Thi Phuong H, Ngan H, Thi H, Thi Thanh B, Dang T, Ho T Protein J. 2024; 43(5):1025-1034.

PMID: 39190120 DOI: 10.1007/s10930-024-10231-y.


Unlocking the specificity of antimicrobial peptide interactions for membrane-targeted therapies.

Conde-Torres D, Calvelo M, Rovira C, Pineiro A, Garcia-Fandino R Comput Struct Biotechnol J. 2024; 25:61-74.

PMID: 38695015 PMC: 11061258. DOI: 10.1016/j.csbj.2024.04.022.